Capital International Investors
PLRX icon

Capital International Investors’s Pliant Therapeutics PLRX Stock Holding History

Capital International Investors’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-224,997
Closed -$2.52M – 469
2024
Q3 		$2.52M Hold
224,997
– – ﹤0.01% 411
2024
Q2 		$2.42M Sell
224,997
-1,152,330
-84% -$14.9M ﹤0.01% 420
2024
Q1 		$20.5M Buy
1,377,327
+464,860
+51% +$7.67M ﹤0.01% 377
2023
Q4 		$16.5M Hold
912,467
– – ﹤0.01% 389
2023
Q3 		$15.8M Hold
912,467
– – ﹤0.01% 388
2023
Q2 		$16.5M Buy
+912,467
New +$21.6M ﹤0.01% 391

Other funds holding PLRX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Capital International Investors's PLRX Position: Q4 2024 in Review

Capital International Investors sold out of Pliant Therapeutics (PLRX) in Q4 2024, closing a stake of 224,997 shares — an estimated $2.52M sold.

Capital International Investors first reported a position in PLRX in Q2 2023 and held it in 6 quarters. The position peaked at $20.5M in Q1 2024. 160 funds tracked by Wall St. Rank hold PLRX as of Q4 2024.

  • Capital International Investors reported no remaining Pliant Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Capital International Investors sold 224,997 Pliant Therapeutics shares in Q4 2024, an estimated $2.52M.
  • Capital International Investors first reported a position in Pliant Therapeutics in Q2 2023 and held it in 6 quarters.
  • Capital International Investors's Pliant Therapeutics position peaked at $20.5M in Q1 2024.
  • 160 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q4 2024.

Based on Capital International Investors's 13F filing for Q4 2024, filed 13 Feb 2025.